PRPL vs RGS

The company is in severe financial distress, evidenced by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.30, indicating negative shareholders' equity. While the company has maintained a healthy gross margin of 40.44% and modest revenue growth of 9.10%, these are overshadowed by consistent net losses and a catastrophic 5-year price decline of 98.2%. The lack of a Graham Number or Intrinsic Value calculation is a direct result of the company's negative earnings and equity. Overall, the deterministic health scores signal a high risk of insolvency.

RGS exhibits classic 'value trap' characteristics, anchored by a weak Piotroski F-Score of 3/9 and severe liquidity distress. While the current price is significantly below the Graham Number ($276.49), this discrepancy is likely due to impaired assets or an unsustainable capital structure, as evidenced by a Current Ratio of 0.53 and a Quick Ratio of 0.28. The anomalous P/E of 0.60 contrasted with a negative Forward P/E of -10.23 suggests a one-time gain masking a collapse in operational earnings. Despite strong top-line revenue growth, the company's financial health is critical, and technical trends remain entirely bearish.